A detailed history of Optiver Holding B.V. transactions in Novartis Ag stock. As of the latest transaction made, Optiver Holding B.V. holds 210,278 shares of NVS stock, worth $22.5 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
210,278
Previous 482,177 56.39%
Holding current value
$22.5 Million
Previous $48.7 Million 58.22%
% of portfolio
0.85%
Previous 1.48%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$95.27 - $108.47 $25.9 Million - $29.5 Million
-271,899 Reduced 56.39%
210,278 $20.3 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $27.9 Million - $30.7 Million
302,390 Added 168.19%
482,177 $48.7 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $17 Million - $18.9 Million
179,787 New
179,787 $18.3 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $23.9 Million - $27.7 Million
-298,790 Reduced 76.32%
92,697 $8.53 Million
Q4 2022

Feb 10, 2023

BUY
$75.55 - $92.52 $15.7 Million - $19.2 Million
207,944 Added 113.29%
391,487 $35.5 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $2.6 Million - $3.04 Million
34,811 Added 23.41%
183,543 $14 Million
Q2 2022

Aug 10, 2022

BUY
$80.52 - $93.75 $12 Million - $13.9 Million
148,732 New
148,732 $12.6 Million
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $27.2 Million - $30.8 Million
-339,452 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $4.39 Million - $4.85 Million
55,065 Added 19.36%
339,452 $29.7 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $22.3 Million - $25.9 Million
272,095 Added 2213.59%
284,387 $23.3 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $39.9 Million - $44.1 Million
-468,320 Reduced 97.44%
12,292 $1.12 Million
Q1 2021

May 20, 2021

SELL
$83.5 - $98.47 $1.12 Billion - $1.32 Billion
-13,404,383 Reduced 96.54%
480,612 $41.1 Million
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $1.16 Billion - $1.37 Billion
13,884,995 New
13,884,995 $1.19 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $230B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.